Brief: Mesoblast To Raise Up To A$97.0 Mln
Dec 4 (Reuters) - Mesoblast Ltd MSB.AX :
* PLACEMENT AND ACCELERATED NON-RENOUNCEABLE ENTITLEMENT
OFFER TO
RAISE UP TO A$97.0M
* PLACEMENT OF UP TO APPROXIMATELY 120 MILLION NEW SHARES AT
AN
OFFER PRICE OF A$0.30 PER NEW SHARE
* APPROXIMATELY 323 MILLION SHARES WILL BE ISSUED UNDER
PLACEMENT
AND ENTITLEMENT OFFER
Source text for Eikon: ID:nASXbvlycf
Further company coverage: MSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast Reports QTRLY Ryoncil Net Revenues Of $30.3 Million
ASX-shares of Mesoblast rise after back-treatment drug hits patent target
Australia's Mesoblast soars on bagging licence for Mayo Clinic-developed tech
Brief: Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products
Brief: Mesoblast Says Ryoncil's Net Revenue For Quarter Increases To US$30.3M